Comparing the Fisher Wallace Stimulator with tDCS
Comparing our device with tDCS (Transcranial Direct Current Stimulation)
Cranial Electrotherapy Stimulation (CES) devices such as the Fisher Wallace Stimulator® are cleared by the FDA for the treatment of insomnia, anxiety, depression and pain.
Transcranial Direct Current Stimulation (tDCS) is not cleared by the FDA for the treatment of depression, anxiety, insomnia or pain. tDCS was FDA approved in 2004 for Iontophoresis, which is a noninvasive method to deliver medicine or other chemicals through the skin with external patches and a small electrical charge. Transcranial Direct Current Stimulation (tDCS) is not typically an at-home treatment modality, and as a result, can be very expensive because it often requires office visits and doctor supervision during treatment sessions. Insurance companies will not reimburse patients for purchasing or using tDCS for “off label” uses such as the treatment of depression.
The nation's top doctors recommend the Fisher Wallace Stimulator® for the safe, at-home treatment of insomnia, anxiety, depression and pain. The Fisher Wallace Stimulator® gently stimulates the brain's production of neurochemicals responsible for improved mood and sleep. In multiple published studies, our technology has been proven to reduce insomnia, anxiety, depression and pain at rates that surpass drug therapy. Our device was cleared by the FDA in 1991 for these indications and causes no serious side effects. It is the most effective brain stimulation device on the market. We offer discounts to patients with Medicare and to those who have served in the Armed Forces – prices start at $595, which includes a 60-day return policy and a 5-year manufacturing warranty.
Insurance companies often reimburse patients for the purchase of our device when it is used to treat pain. If the Fisher Wallace Stimulator® does not reduce your symptoms of insomnia, anxiety, depression and/or pain within 60 days of receipt, you may return the device for a refund.